Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
- Status
- COMPLETED
- Phase
- NA
Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment
- Status
- UNKNOWN
- Phase
- N/A
Proteomics and Stem Cell Therapy as a New Vascularization Strategy
- Status
- COMPLETED
- Phase
- NA
Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Filgrastim for Premature Ovarian Insufficiency
- Status
- COMPLETED
- Phase
- PHASE4
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1